Blurred Vision (Vision Blurred): Drugs With FDA Adverse Event Reports | PillSignal

These are medications for which blurred vision appears among the most-reported events in FDA adverse event reports. A report does not mean the drug caused the event. Report counts largely reflect how widely a drug is used and how often events are reported; they cannot be used to compare or rank drugs by risk. This list shows drugs where this event is among their top reported reactions, not every drug ever associated with it. This information is not medical advice. Do not stop or change a medication based on this data; discuss any concerns with your healthcare provider. Data from the FDA Adverse Event Monitoring System (AEMS), formerly FAERS, via OpenFDA.

A loss of sharpness in vision, making things look out of focus. Full definition in the glossary →

Medications with FDA adverse event reports of blurred vision, by report count
Drug	Reports of this event	% of drug's total reports
Dupixent	6,261	1.4%
Lyrica	5,493	2.1%
Restasis	2,630	3.0%
Gilenya	2,535	3.1%
Xalatan	1,459	3.0%
Lucentis	1,030	3.9%
Cialis	958	1.8%
Ozempic	939	1.5%
Xelpros	936	2.9%
Latanoprost	914	2.9%
Pegasys	826	1.5%
Viagra	803	1.3%
VESIcare	789	3.1%
Vesicare Ls	789	3.1%
Zyprexa Relprevv	724	1.8%
Botox Cosmetic	622	1.6%
Lumigan	604	3.2%
Pristiq Extended-release	357	1.5%
Trintellix	356	2.1%
Flomax	347	1.8%
Sovaldi	274	1.4%
Latisse	265	2.4%
Claravis	197	0.9%
Amnesteem	191	1.0%
Detrol LA	190	1.8%
Ingrezza	180	0.7%
Vraylar	126	1.4%
Rybelsus	119	1.8%
Boniva	65	2.2%

← All adverse event pages